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ABSTRACT   
Two groups of experienced radiologists from the UK and the USA read the same set of 40 recent FFDM screening cases 
to examine the effects of mammography experience, volume of cases read per year, screening  practice and monitor 
resolution on performance,.  Sixteen American radiologists reported these cases using twin DICOM calibrated monitors 
which were half the resolution of the clinical mammographic workstations used by 16 UK radiologists. In terms of 
effects of volume of cases read per year, then when the group of American radiologists were split into high and low 
volume readers (using 5,000 cases p.a. as a criterion) no difference in any performance measure was found.  This may be 
partly explained by the fact that they were all were very experienced which may have counteracted any case volume 
effect here.  Comparing the two groups of radiologists from both countries, then the UK group performed better in terms 
of the number of cancers detected although the American group recalled more cases, despite having poorer monitors.  
This reflects differences in clinical screening practice between the countries, however differences simply due to the 
reporting monitors used cannot be ruled out. Data from the study were also compared to that from all UK screeners who 
had read these cases as either soft copy or as mammographic film. 
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1. INTRODUCTION  
Breast cancer is a disease which affects one in eight women in the UK and the USA at some point in their lives1,2.  The 
best way to minimize the effects of this cancer is to detect it as early as possible and consequently many countries have 
instituted nationwide screening programmes. These operate differently in each country.  The UK has a centrally 
organized national breast cancer screening programme (NHSBSP) under the auspices of the National Health Service 
which has run successfully for some 23 years.  Currently the programme screens over 2 million women every three years 
aged between 45 and 74 years3.  This programme was originally established using mammographic film and has for many 
years imaged each woman using two mammographic views (the Medio-Lateral Oblique and Cranio-Caudal) but is 
currently very rapidly changing to employing similar two-view Full Field Digital Mammography (FFDM).  All breast 
screening radiologists and advanced practitioners (specially trained technologists who also read and interpret screening 
mammographic cases) have to read a minimum of 5,000 cases a year in order to take part in the national breast screening 
programme4.  Despite the headline figure of breast cancer affecting 1 in 8 women the incidence in the screened 
population is actually very low per 1,000 women screened; consequently this annual high number of cases read ensures 
that every individual experiences a high number and range of normal as well as abnormal cases.  The number of women 
recalled after screening for subsequent examinations in the UK is kept low, circa 4.2% nationally3. 
 
In the USA the organization of breast screening is somewhat different.  American breast screening radiologists typically 
read a much lower annual volume of cases; the American College of Radiology specifies as part of the mammography 
accreditation program that an interpreting physician should interpret 960 mammographic examinations over a two year  
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period as part of continuing experience5.  Additionally, in the USA more women are recalled as compared to in the UK, 
with one study, reporting on real life data, figures of 13.3% as compared to 7.2%6 in the UK in this study6.  This reflects 
differences between the two countries in their approach to screening practice.   
 
If the volume of cases read relates to the ability to more readily determine whether a case should be recalled or not then 
performance differences between the two countries would be expected in any experimental comparison between 
radiologists from these countries.  As part of the UK screening programme all screeners undertake the annual 
PERFORMS scheme which has been well described previously7,8.  This is an educational exercise where screeners 
examine sets of recent difficult cases containing a range of mammographic features, receiving immediate feedback as 
well as more detailed feedback some time later when their performance data are compared anonymously to that of their 
peers.   
 
This present study investigated what happens when experienced breast screening radiologists from both countries 
examined the same FFDM case set from the PERFORMS scheme, albeit using different resolution displays, as a first 
step in a more detailed study using comparable displays. Breast screening experience and the volume of screening cases 
read per year are known key predictors of an individual’s screening performance.  Additionally, high resolution 
mammography workstations are a clinical requirement for soft copy reporting of FFDM images. Notwithstanding this, 
our previous work9  has demonstrated that good performance in identifying abnormalities on screening mammograms 
can be achieved using a single office monitor with suitable image manipulation software as compared to a clinical 
mammography workstation when the same UK screeners read the same cases on different occasions.  In the present 
study the effects of differences in experience, case volume per annum and monitor resolution were investigated.  
Comparative data involving UK and USA radiologists interpreting the same test case set of digital screening 
mammograms which examines screening practices, screening experience, case volume and reporting monitor resolutions 
have not previously been investigated. 
 
2. METHOD 
2.1  USA group 
 
The opportunity arose to demonstrate the PERFORMS scheme to a number of leading American radiologists involved in 
breast screening who were examiners at the American Board of Radiology board certification examinations in Louisville 
(2011).  During these board examination the examiners had breaks in their schedules where they were then timetabled to 
take part and experience aspects of the PERFORMS scheme.  In the UK radiologists undertaking PERFORMS will read 
two sets of 60 difficult cases per annum and on each occasion they can spend a variable amount of time in doing this.  In 
Louisville, as the available time to participate was limited for each examiner, then we deliberately restricted the number 
of cases that they examined to 40.  Efforts to acquire clinical mammographic workstations for these participants in this 
investigation, unfortunately proved to be unsuccessful and consequently a test room was set up with four workstations, 
each comprising a PC running dual 20” DICOM calibrated monitors.  The test room lighting was reduced and measured 
to reflect typical screening room light levels for digital mammography reporting.  Each radiologist interpreted 40 
difficult FFDM cases from a recent set of PERFORMS test cases.  Due to the limits of the monitor resolution these cases 
were carefully selected so as to exclude any small micro-calcifications which would be expected not to have visualized 
well on these monitors.  
 
For each of the four workstations the case set of 40 images was loaded  and a dedicated PERFORMS tablet computer set 
up.  This device ran the PERFORMS reporting software which the user first logs into.  It then presents a matrix of cases 
to select and examine, starting with practice cases. The user selects a case on the tablet and the corresponding FFDM 
images on the workstation. They then examine the workstation images and make responses on the tablet using a 
graphical user interface.  For each case the user decides whether various mammographic features are present or not and 
locates these on small images of the mammographic cases on the tablet computer.  They also decide how they would 
classify each breast; ranging from normal, benign to malignant and whether or not they would recall each breast.  In 
doing this a rating scale is used which is broadly similar to BIRADS10 but which follows the UK classification 
approach11.  Because of this difference in scoring method each participant was first led through the practice cases and 
how to utilize the reporting process by one of the experimenters in order to familiarize the participants with the process. 
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Once they were comfortable with the use of the DICOM image viewer employed here as well as the reporting software 
then the experimental study began and they read the reported the 40 cases in their own time and at their own rate.  After 
participating, each individual completed a short questionnaire concerning their usual screening practice including such 
questions as how many cases a year they read and for how many years they had been involved in mammography. 
 
2.2  UK group 
For comparison purposes the anonymous data were used of 16 experienced UK breast radiologists out of over several 
hundred who had previously read the same cases as part of a recent round of the PERFORMS scheme using their usual 
clinical mammographic workstations.  These individuals were randomly selected from all those who had recently read 
the latest PERFORMS test set of 60 cases as soft copy images.  For each radiologist their anonymous data were extracted 
for the 40 cases which were used here in this study.   
 
Secondly, data from the study were compared to the anonymous data of all UK participants in the scheme for these 40 
cases who had read the cases as soft copy.  This included data for both breast screening radiologists and advanced 
practitioners who are specially trained technologists who read screening cases in the UK. 
 
3. RESULTS  
 
3.1 USA group 
It is well documented that the volume of cases read typically affects screening performance.  Out of the 16 American 
radiologists a number reported that they annually read over 5,000 cases and the rest read less than this.  As this is the 
same criterion volume of cases that UK radiologists must read in order to participate in breast screening in the UK then 
the American group were first split according to this reported number into two sub-groups of low (<5,000) and high 
annual volume (=>5,000) of screening cases read in order to examine whether reported volume was related here to their 
performance on this test set. All of these radiologists also reported that they had been involved with mammography for 
over 15 years.  In terms of the study experience they all reported finding the PERFORMS case set a very interesting 
educational experience. 
 
In the PERFORMS scheme there are several performance metrics which are used.  Here, the three key performance 
measures of malignancies correctly identified, coupled with the decisions of whether or not a case should be recalled 
(correct recall) or returned to routine screening (correct return to screen) were examined.  These data were calculated and 
compared between these two sub-groups. No significant differences were found (t=0.23, p=n.s) and consequently, the 
performance data of these two sub-groups were combined in the subsequent analyses.  
 
3.2  Comparison of USA and UK performances 
The data of the 16 American radiologists were then compared to that of the selected 16 UK radiologists on the screening 
metrics. There was no significant difference (figure 1) between these two groups in correct recall (CR) decisions (UK: M 
= 90.7%. SE = 1.05, p = n.s.; USA: M = 92.3%, SE = 1.93,  p = n.s.).  Also, there was no significant difference between 
these two groups in Negative Predictive Value (NPV) decisions (UK: M = 95.7%. SE = 0.45; USA: M = 96.9%, SE = 
0.74 p = n.s). Furthermore, there was no significant difference (figure 2) between these two groups in Az scores (UK: M 
= 0.97 SE = 0.01; USA: M = 0.95, SE =0.01 p = n.s).   
 
However, there were significant differences (figure 1) in correct return to screening (CS) decisions (UK: M = 89.8%, SE 
= 1.70; USA: M = 81.1%, SE = 1.94; p<0.05) and in the percentages of malignancies (CD) detected (UK: M = 99.7%, 
SE = 0.28; USA: 92.3%, SE = 1.94; p<0.05) and in the Positive Predictive Value (PPV) percentages (UK: M = 81.3%, 
SE = 2.56; USA: M = 65.0%, SE=2.43; p<0.05). 
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Figure 1.  Performance values comparing 16 USA radiologists and 16 UK radiologists 
 
 
 
Figure 2.  Az values comparing 16 USA radiologists and 16 UK radiologists 
 
3.3  Further UK – USA comparisons 
The data of the 16 American radiologists were then compared on the screening metrics to that of all UK radiologists who 
had read these cases as soft copy images. There was no significant difference (figure 3) between these two groups in 
correct recall (CR) decisions (UK: M = 92.2%. SE = 0.47; USA: M = 92.3%, SE = 1.93, p = n.s.).  Also, there was no 
significant difference between these two groups in NPV decisions (UK: M = 97.2%, SE = 0.16, USA: M = 96.9%, SE = 
0.74, p = n.s). No significant difference was also between these two groups in cancer detection (CD) percentages (UK: M 
= 92.2%, SE = 0.004; USA: M = 92.3%, SE = 0.19, p = n.s).   
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However, there were significant differences in correct return to screening (CS) decisions (UK: M = 88.5%, SE = 0.47; 
USA: M = 81.1%, SE = 1.94; p<.05) and in PPV percentages  (UK: M = 76.3%, SE = 0.67; USA: M = 64.9%, SE = 2.43, 
p<.05) and in the Az scores (figure 4) (UK: M = 0.97, SE = 0.001; USA: M = 0.95, SE = 0.008, p<.05). 
  
 
 
 
Figure 3.  Performance values comparing 16 USA radiologists and UK screeners 
 
 
 
 
Figure 4.  Az values comparing 16 USA radiologists and UK screeners 
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4. DISCUSSION 
 
This study is the first step in investigating how experienced breast screening radiologists from the UK and USA fare 
when examining the same FFDM cases and using the same reporting software. Previously we have carried out a 
somewhat similar exercise in comparing how two groups from these countries have read a PERFORMS scheme test set 
of mammographic films using multi-viewers12. In the present study the American group unfortunately only had access to 
monitors which had approximately half the resolution of a mammographic workstation and therefore would have had 
difficulty in visualizing small micro-calcifications.  To counter this to some extent, the cases which were used were 
carefully selected so as not to have significant micro-calcifications.  We have previously shown that acceptable 
performance can be obtained when the same group of screeners examined a case set using either their clinical 
mammographic workstations or a single office monitor as long as suitable interaction software is utilised9.  The reporting 
software was new to the American group, however it is a transparent reporting system which has been well researched to 
be very user friendly.  The software does not use the BIRADS categorization but a close approximation and in practice 
none of the American group had difficulty in using it.   
 
Somewhat in contrast, comparative data were used here from 16 randomly selected experienced UK radiologists to form 
the UK group which had several advantages – they had utilized their routine clinical workstations to examine the cases 
on and were familiar with the reporting software which has been in use in the UK annually for circa seven years.  
 
Examining the data from Louisville firstly split into high and low volume of cases read per annum yielded no significant 
differences.  On the face of it this is somewhat surprising as usually better performance in breast screening relates to the 
volume of cases an individual reads.  However, here the radiologists were all very experienced in mammography and 
thus even the low volume readers had had considerable years of expertise in examining mammograms.  It is always 
difficult to tease out experience and volume of cases read as independent factors as inevitably the two are intrinsically 
related.  We have previously reported that volume of cases read is important12, 13 when examining performance on the 
scheme.  Furthermore, when we earlier examined the data of 450 participants on the PERFORMS scheme and related 
this to their real life volume of cases read per annum and years of screening experience it was found that years of 
experience was much more important than volume of cases read14.  Somewhat relatedly, Beam, Conant and Sickles15 
have reported in an American study that current reading volume was not significantly related to accuracy with expertise 
reflecting ‘a complex multifactorial process’. 
 
Comparing how these 16 radiologists fared to 16 experienced UK radiologists demonstrated that both groups somewhat 
similarly correctly recalled those cases which should be recalled, based on known case pathology and actual screening 
outcome. Significant differences were found in decisions of correctly returning cases to screening (i.e. judging that a case 
was normal or benign and not worthy of further investigation at that time), percentages of malignancies detected and in 
PPV. This is as predicted based on differences between the two countries in routine screening practices where the 
American group over-read cases as compared to the UK group. That the UK group detected significantly more 
malignancies probably reflects the differences here in the workstation monitors employed. 
 
The American group, notwithstanding the poorer monitors used here, were then compared to the whole of the UK 
screening programme who had participated in reading these same cases because this would then encompass a wider 
spectrum in the UK of screening behaviours.  Again, broadly similar results were found in that the American group over-
read the case set as compared to all the UK participants. 
 
5. CONCLUSIONS 
The purpose of the study was primarily to examine what happens when two groups of experienced breast screeners from 
different routine clinical screening practices examine the same set of difficult cases.  Unfortunately it was not possible 
here for both groups to utilize clinical mammographic workstations.   Despite this, the use of lower resolution monitors 
by the American group was clearly offset by their experience in mammography (all  > 15 years) such that even the very 
experienced  but low reported volume readers performed well with there being no significant differences between the 
two American sub-groups, split by reported volume of cases read per annum.  
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Not surprisingly, the comparative selected UK group of 16 radiologists overall performed better in reporting these test 
cases as they were using high resolution mammographic workstations.  However, the American group still recalled more, 
reflecting their real life screening practice.  Examining how the American group did as compared to all UK screening 
radiologists and advanced practitioners who had read the same cases as soft copy demonstrated that the performance data 
for the American radiologists were broadly comparable to those of UK participants.  
  
The second part of this study will take place in 2012 at Louisville with an American group of experienced radiologists 
using clinical mammographic workstations and it is hoped that this will give yet more insight into the factors underlying 
screening performance in these two countries.  The PERFORMS scheme was specifically designed for individual 
screeners in the UK to enable them to gain insights into their performance in identifying early signs of cancer as well as 
how well they perform as compared to colleagues.  This study demonstrates that screeners from outside the UK can use 
the scheme equally well and report finding it a useful educational aid. 
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